ESH International Conference IMMUNE THROMBOCYTOPENIA

Immune thrombocytopenia (ITP) is a bleeding disorder characterized by the induction of an autoreactive immune response against one’s own platelets, resulting in increased platelet destruction and reduced megakaryocyte function.  In the last 10 years, many publications have shed new light on several clinical and scientific questions relating to ITP.  It is now clear that ITP may have more than one etiology and is a complex and heterogeneous disorder and new clinical definitions of the disease have arisen.   Perhaps more striking is the rapid evolution of novel therapeutics that have shown great benefit to even the most refractory of patients with ITP and these have been incorporated into new consensus guidelines.  This meeting will bring together many of the world’s leading clinical and scientific experts on ITP and will present a comprehensive program of lectures and posters to summarize the current state-of the-art knowledge and treatments of ITP.